Plain-English translation of NCT07113665 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing MR-guided focused ultrasound capsulotomy, a precise ultrasound procedure performed inside an MRI scanner that targets a specific area deep in the brain. The treatment is designed for people with severe, long-standing anorexia nervosa who have tried multiple treatments without sustained improvement and who also struggle with obsessive-compulsive disorder or major depression. This medication works by using heat to gently lesion a tiny area believed to be involved in both eating behaviors and mood regulation.
Anorexia nervosa is a life-threatening condition, and when standard treatments like therapy and hospitalization don't work, patients have very few options left. This trial exists to see whether the new treatment might help people whose eating disorder has become resistant to conventional care, especially when accompanied by anxiety or depression.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will first have detailed evaluations including psychiatric interviews, physical exams, blood tests, and MRI brain imaging to make sure the procedure is safe for you. On the day of treatment, you will lie still on an MRI table while the focused ultrasound procedure is performed—the entire process is guided by real-time MRI imaging so doctors can see exactly where they are treating. After the procedure, you will have follow-up visits at regular intervals (1, 3, 6, 12, 18, and 24 months) to check your safety and see whether your eating disorder, mood, and anxiety symptoms improve.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Canada